Department of Neurology, Hanyang University College of Medicine, 249-1 Gyomun-dong, Guri-si, Gyeonggi-do, South Korea.
Department of Translational Medicine, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, South Korea.
Mol Neurobiol. 2016 Jan;53(1):695-705. doi: 10.1007/s12035-014-9030-0. Epub 2015 Jan 11.
Although statins, or hydroxymethylglutaryl coenzyme A (HMG-Co A) reductase inhibitors, are generally used to decrease levels of circulating cholesterol, they have also been reported to have neuroprotective effects through various mechanisms. However, recent results have indicated that they may be harmful in patients with amyotrophic lateral sclerosis (ALS). In this study, we investigate whether atorvastatin protects motor neuron-like cells (NSC-34D) from oxidative stress. To evaluate the effects of atorvastatin or hydrogen peroxide or both on NSC-34D cells, the cells were treated with various combinations of these agents. To evaluate the viability of the cells, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays and trypan blue staining were performed. Levels of free radicals and intracellular signaling proteins were evaluated using the fluorescent probe 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) and Western blotting, respectively. Atorvastatin protected NSC-34D cells against oxidative stress in a concentration-dependent manner. This neuroprotective effect of atorvastatin was blocked by LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor and by FR180204, a selective extracellular signal-related kinase (ERK) inhibitor. Atorvastatin treatment increased the expression levels of p85αPI3K, phosphorylated Akt, phosphorylated glycogen synthase kinase-3β, phosphorylated ERK, and Bcl-2, which are proteins related to survival. Furthermore, atorvastatin decreased the levels of cytosolic cytochrome C, Bax, cleaved caspase-9, and cleaved caspase-3, which are associated with death in oxidative stress-injured NSC-34D cells. We conclude that atorvastatin has a protective effect against oxidative stress in motor neurons by activating the PI3K and ERK pathways as well as by scavenging free radicals. These findings indicate that statins could help protect motor neurons from oxidative stress.
尽管他汀类药物,或羟甲基戊二酰辅酶 A(HMG-CoA)还原酶抑制剂,通常用于降低循环胆固醇水平,但它们也通过各种机制显示出神经保护作用。然而,最近的结果表明,它们在肌萎缩侧索硬化症(ALS)患者中可能是有害的。在这项研究中,我们研究了阿托伐他汀是否能保护运动神经元样细胞(NSC-34D)免受氧化应激。为了评估阿托伐他汀或过氧化氢或两者对 NSC-34D 细胞的影响,用这些药物的各种组合处理细胞。为了评估细胞的活力,进行了 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)测定和台盼蓝染色。使用荧光探针 2',7'-二氯二氢荧光素二乙酸酯(DCFH-DA)和 Western blot 分别评估自由基和细胞内信号蛋白的水平。阿托伐他汀以浓度依赖的方式保护 NSC-34D 细胞免受氧化应激。这种阿托伐他汀的神经保护作用被磷脂酰肌醇 3-激酶(PI3K)抑制剂 LY294002 和选择性细胞外信号相关激酶(ERK)抑制剂 FR180204 阻断。阿托伐他汀处理增加了与存活相关的 p85αPI3K、磷酸化 Akt、磷酸化糖原合成酶激酶-3β、磷酸化 ERK 和 Bcl-2 的表达水平。此外,阿托伐他汀降低了细胞溶质细胞色素 C、Bax、裂解的 caspase-9 和裂解的 caspase-3 的水平,这些蛋白与氧化应激损伤的 NSC-34D 细胞中的死亡有关。我们得出结论,阿托伐他汀通过激活 PI3K 和 ERK 途径以及清除自由基,对运动神经元的氧化应激具有保护作用。这些发现表明,他汀类药物可以帮助保护运动神经元免受氧化应激。